FDA issued a Warning Letter to Zhejiang Hisun Pharmaceutical Co., Ltd. on 12/31/2015 as a result of this inspection.
FDA investigators audited the Zhejiang Hisun Pharmaceutical - Taizhou, China facility and issued 8 inspectional observations (via FDA 483) on 07 Mar 2015.
Add To Cart
- Category: Animal Drugs & Feeds / Human Drugs
- Number of Observations: 8
- Inspection end: 07 Mar 2015
- Location: Taizhou, China
- FEI: 3007719313